Long-term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®-ON.
Jin Woo SongTakashi OguraYoshikazu InoueZuojun XuManuel QuaresmaSusanne StowasserWibke StansenBruno CrestaniPublished in: Respirology (Carlton, Vic.) (2019)
The effect of nintedanib on slowing disease progression in Asian patients with IPF is sustained over the long term. Long-term treatment with nintedanib has an acceptable safety and tolerability profile.